Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.

It’s increasingly hard to find a bodily system that isn’t touched in some way by the drugs. Researchers are also investigating how these drugs might affect fertility and exploring their ...

In drug discovery ... Alnylam’s chief technology officer. In this way, the RNAi therapeutic platform is analogous to a computer operating system like iOS or Android; scientists can use the ...

A unique peek inside the human brain may help explain how it clears away waste like the kind that can build up and lead to ...

A man jailed for his role in a million-pound drug dealing operation has spoken of how his time in prison offered him a “way out” of the ... Samantha Graham, CEO of Clean Sheet, which helps ...

It develops therapies and vaccines that strengthen the natural immune system to fight cancer and infectious diseases. The company’s leading drug is Anktiva. It’s testing Anktiva in combination ...

Numerous drugs are available, but there’s no clear consensus about which ones perform best. To address this, researchers trawled scientific databases to identify randomised controlled trials ...

Nootropics come in natural nootropics, such as Bacopa Monnieri and Rhodiola Rosea, and formulated nootropic supplements like ...

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...

Investors have plenty to feel positive about. Inflation is easing, with the latest data showing an annualized rate of 2.4%, ...

Democrat Marie Gluesenkamp Perez of Washington and Republican Lori Chavez-DeRemer of Oregon are defending seats that could be ...

The polls are open in the 43rd British Columbia provincial general election, marking the conclusion of a four-week campaign ...